Skip to main content
. 2023 Nov 8;9(4):e003426. doi: 10.1136/rmdopen-2023-003426

Table 4.

Definitions of outcome in SSc-ILD

SSc mixed cohorts SSc-ILD cohorts
Time, months
(n papers)
n patients (n papers) n ILD patients (n papers) n of patients with outcome (n papers) References Time, months
(n papers)
n patients (n papers) n of patients with outcome (n papers) References
Mortality due to ILD 180 (12) 6165 (12) 2628 (10) 277 (12) 23 24 65 118 138 167 263–267
SSc-related mortality 25-
200 (7)
UNK (1)
3789 (7) 1785 (7) 324 (7) 23 65 264 266 268 269 97 (1) 306 (1) 39 (1) 17
15-year mortality 1284 (1) 522 (1) 260 (1) 270 106 (1) 21 (1) 154
10-year mortality 7484 (13) 2509 (10) 1991 (13) 23 78 106 111 130 179 214 267 268 271–273 223 (3) 46 (3) 144 150 274
5-year mortality 10 604 (16) 4335 (15) 1104 (13) 23 84 106 111 173 225 242 267 268 271–273 275–277 436 (6) 117 (6) 274 278–282
3-year mortality 1046 (5) 688 (5) 134 (5) 158 173 242 268 275 264 (5) 25 (5) 127 152 279 281 283
1-year mortality 1153 (5) 633 (5) 33 (2) 254 268 272 273 275 314 (8) 12 (6) 280–287
Mortality 12–36036 23 366 (35) 5048 (26) 2338 (31) 5 8 23 25 64–66 92 114 117–119 131 147 160 174 177 219 244 266–268 288–300 12–348 (32) 3028 (31) 582 (27) 17 28 50 71 85 128 141 142 149 151 153 163 170 185 226 238 242 258 269 274 278 301–311
In-hospital mortality 120 (1)
12 (1)
Unk (3)
14 240 (4) 1899 (3) 164 (3) 312–316
Mortality after lung transplantation 45–721 72 (1) 27 (1) 317
Hospitalisation 12 (1)
120 (2)
84 (1)
Unk (3)
6211 (5) 1261 (4) 591 (4) 312 314 316 318 319 12 (1) 574 (1) 78 (1) 166
End-stage ILD 12 (1)
60 (1)
120 (1)
200 (2)
1646 (5) 451 (4) 111 (5) 65 245 320–322 173 (1) 50 (1) 16 (1) 323
Lung transplantation 120 (1) 200 (1) 552 (2) 203 (2) 17 (2) 65 179 60 (1) 172 (1) 3 (1) 301
Infections 120 (1) 95 (1) 36 (1) 26 (1) 312 120 (1) 46 (1) 9 (1) 144

ILD, interstitial lung disease; SSc, systemic sclerosis; Unk, unknown/not specified.